Allergan Biocell Textured Breast Implant Lawsuits To Be Selected For Bellwether Trial Discovery in August 2024
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Breast Implant Lawsuit Claims Woman Repeatedly Misdiagnosed Due To Lack Of Cancer Warnings November 20, 2019 Irvin Jackson Add Your Comments Allergan’s efforts to hide information about the link between its Biocell breast implants and cancer allegedly resulted in a woman being misdiagnosed on multiple occasions, according to a recently filed product liability lawsuit. Misty Riportella filed the complaint (PDF) earlier this month in the U.S. District Court for the Southern District of California, indicating that her cancer treatments were delayed due to Allergan’s failure to warn consumers and the medical community about the risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), which has been linked to certain textured designs. Riportella indicates that she received textured McGhan Style 168 implants in March 2000, and began to experience a rash on her lower back in 2011, as well as sore muscles, loss of energy, tingling and trouble breathing. As a result of the health issues, she was eventually unable to continue her employment, and has undergone multiple imagine studies, blood workups and batteries of tests to resolve the symptoms. Learn More About Breast Implant Lawsuits Women may face a risk of Anaplastic Large Cell Lymphoma (ALCL) from certain breast implants. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Breast Implant Lawsuits Women may face a risk of Anaplastic Large Cell Lymphoma (ALCL) from certain breast implants. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Throughout the years, Riportella indicates that different physicians misdiagnosed her with a number of different health conditions, including congestive heart failure, COPD, blood flow issues and other problems. In February 2019, after her daughter noticed significant swelling on one of her breasts, Riportella was seen in the emergency room and referred to other doctors, who eventually diagnosed her with BIA-ALCL in June 2019. “Plaintiff Misty Riportella’s case exemplifies what a manufacturer’s failure to warn the FDA and thus doctors of adverse events and associated risks of significant injury means in terms of a patient being able to obtain an accurate diagnosis,” the lawsuit states. “Ms. Riportella was mistakenly diagnosed with a whole host of issues for years until ultimately she received lab results confirming the presence of Breast Implant Associated-Anaplastic Large Cell Lymphoma.” While the manufacturer knew or should have known about the risk of lymphoma from textured breast implants, according to allegations raised in the complaint, Allergan chose to ignore the evidence for years. Around the time Riportella was properly diagnosed with cancer from the breast implants, recalls were issued in Canada, Australia, France and other countries for certain types of Allergan breast implants featuring the Biocell textured design. In July 2019, the manufacturer finally agreed to issue a breast implant recall in the United States, removing all of products featuring the microtextured design from the market. At that time, the FDA indicated that it was aware of 573 known cases of BIA-ALCL worldwide, including 33 deaths. Of those, 481 involved Allergan breast implants. Allergan implants were also linked to 12 of the 13 deaths where the manufacturer of the breast implant was known. Riportella’s complaint joints a number of Allergan breast implant ALCL lawsuits now being filed by women who indicate they would have avoided this rare cancer if earlier warnings and information had been provided by the manufacturer. Tags: Allergan, Allergan Biocell, Anaplastic Large Cell Lymphoma, Breast Implant, Breast Implant Cancer, Breast Implant Lymphoma, Cancer Image Credit: | More Breast Implant Lawsuit Stories Study Finds Rising Breast Cancer Rates Among Young Women October 14, 2024 Allergan Biocell Textured Breast Implant Lawsuits To Be Selected For Bellwether Trial Discovery in August 2024 June 14, 2024 Breast Implant Squamous Cell Carcinoma Rate Appears to Be Very Low: Study April 26, 2023 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: today) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025) Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: yesterday) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025) Salon Professionals Claim Occupational Exposure to Hair Dye Products Caused Bladder Cancer: Lawsuits (Posted: 4 days ago) Two California hair stylists filed separate lawsuits, indicating that repeated occupational exposure to toxic chemicals in hair coloring dyes caused them to develop bladder cancer. MORE ABOUT: HAIR DYE LAWSUITHair Color Lawsuit Filed Over Salon Worker’s Bladder Cancer Diagnosis (03/20/2025)Brazilian Blowout Cancer Lawsuit Filed by Missouri Hair Stylists Over Exosure to Toxic Chemicals (03/11/2025)Initial Status Conference for Hair Dresser’s Bladder Cancer Lawsuit Set for May 5 (03/10/2025)
Allergan Biocell Textured Breast Implant Lawsuits To Be Selected For Bellwether Trial Discovery in August 2024 June 14, 2024
Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: today) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)
Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: yesterday) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)
Salon Professionals Claim Occupational Exposure to Hair Dye Products Caused Bladder Cancer: Lawsuits (Posted: 4 days ago) Two California hair stylists filed separate lawsuits, indicating that repeated occupational exposure to toxic chemicals in hair coloring dyes caused them to develop bladder cancer. MORE ABOUT: HAIR DYE LAWSUITHair Color Lawsuit Filed Over Salon Worker’s Bladder Cancer Diagnosis (03/20/2025)Brazilian Blowout Cancer Lawsuit Filed by Missouri Hair Stylists Over Exosure to Toxic Chemicals (03/11/2025)Initial Status Conference for Hair Dresser’s Bladder Cancer Lawsuit Set for May 5 (03/10/2025)